Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets (Unaudited)

v3.23.1
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
Mar. 31, 2023
Dec. 31, 2022
Current assets:    
Cash and cash equivalents $ 9,769,088 $ 11,413,759
Accounts and other receivables, net 11,027 10,489
Inventory 11,335 5,540
Prepaid and other current assets 441,132 531,899
Total current assets 10,232,582 11,961,687
Property and equipment, net 225,067 214,438
Other assets 6,920 6,000
Total assets 10,464,569 12,182,125
Current liabilities:    
Accounts payable 146,537 345,042
Accrued expenses 481,336 541,894
Loan payable 168,430 251,746
Total current liabilities 796,303 1,138,682
Total liabilities 796,303 1,138,682
Commitments and contingencies (See Note 8)
Stockholders’ equity:    
Preferred stock, par value $0.001 per share; 20,000,000 shares authorized; no shares issued or outstanding at March 31, 2023, and December 31, 2022
Common stock, par value $0.007 per share; 14,285,714 shares authorized; 8,463,052 issued and outstanding at March 31, 2023; and 8,381,324 shares issued and outstanding at December 31, 2022 59,241 58,669
Additional paid-in capital 47,809,283 47,652,242
Accumulated deficit (38,200,258) (36,667,468)
Total stockholders’ equity 9,668,266 11,043,443
Total liabilities and stockholders’ equity $ 10,464,569 $ 12,182,125